Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 138
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout
It’s Time to Push Back: Meta’s War on Psychedelic Voices
Victoria Litman – The Future of Psychedelic Regulation Is Local
Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber;...
Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin Results
Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine...
Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment...
Optimi Health Enters Into International Collaborative Research and Supply Agreement With...
Bright Minds Biosciences Announces Closing of $4 Million Unit Offering
Mindset Pharma to Participate in the H.C. Wainwright 24th Annual Global...
Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S....
PT351 – Seth Rosenberg – The Trauma In Being Arrested and...
PsyBio Therapeutics Reports Second Quarter 2022 Financial Results
Wesana Announces Second Quarter 2022 Financial Results
Psychedelic Bulletin #116 – Ketamine Combo Co. Scores $10m; DEA Drops...
1
...
137
138
139
...
291
Page 138 of 291
